Completed PHASE2 INTERVENTIONAL 2-arm NCT02851173

Cognitive Enhancement Through Transcranial Laser Therapy (LLLT)

Sponsor: University of Texas at Austin

Conditions Healthy Participants Mild Cognitive Impairment

Updated 11 times since 2017 Last updated: Sep 14, 2023 Started: Feb 21, 2016 Primary completion: Apr 30, 2020 Completion: Apr 30, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Healthy Participants and Mild Cognitive Impairment and is currently completed. University of Texas at Austin leads this study, which shows 11 recorded versions since 2016 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

11 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Nov 2023 — Jul 2024 [monthly]

Completed PHASE2
Jun 2021 — Nov 2023 [monthly]

Completed PHASE2

Status: Recruiting → Completed
Jan 2021 — Jun 2021 [monthly]

Recruiting PHASE2

▶ Show 6 earlier versions

Mar 2019 — Jan 2021 [monthly]

Recruiting PHASE2
Jun 2018 — Mar 2019 [monthly]

Recruiting PHASE2
Sep 2017 — Jun 2018 [monthly]

Recruiting PHASE2
Mar 2017 — Sep 2017 [monthly]

Recruiting PHASE2

Status: Not Yet Recruiting → Recruiting
Feb 2017 — Mar 2017 [monthly]

Not Yet Recruiting PHASE2
Jan 2017 — Feb 2017 [monthly]

Not Yet Recruiting PHASE2

First recorded

Feb 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Texas at Austin

Data source: University of Texas at Austin

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Austin, United States